December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Evaluation of the COL8A1 Gene in Patients with Fuchs' Endothelial Dystrophy of the Cornea
Author Affiliations & Notes
  • SA Hagstrom
    Cole Eye Institute Cleveland Clinic Foundation Cleveland OH
  • GT Pauer
    Cole Eye Institute Cleveland Clinic Foundation Cleveland OH
  • L Kleihenz
    Hathaway Brown School Shaker Heights OH
  • K Zhang
    Cole Eye Institute Cleveland Clinic Foundation Cleveland OH
  • Footnotes
    Commercial Relationships   S.A. Hagstrom, None; G.T. Pauer, None; L. Kleihenz, None; K. Zhang, None. Grant Identification: Cole Eye Institute, Heed Ophthalmic Foundation, Kirchgessner Foundation
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1730. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      SA Hagstrom, GT Pauer, L Kleihenz, K Zhang; Evaluation of the COL8A1 Gene in Patients with Fuchs' Endothelial Dystrophy of the Cornea . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1730.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Fuchs' endothelial dystrophy of the cornea (FECD) is a primary disorder of the corneal endothelium and is one of the most common indications of corneal transplantation performed in developed countries. The COL8A2 gene encodes the α2 chain of type VIII collagen and is a major component of endothelial basement membranes, including human corneal Descemet's membrane. Recently, missense mutations in the gene have been identified in patients with FECD. Type VIII collagen is comprised of two α chains, α1 and α2, that exist in vivo as hetero-or homotrimers. These findings prompted us to investigate the COL8A1 gene that encodes the α1 chain of type VIII collagen on chromosome 3q11 as a candidate gene for FECD. Methods: To date, a partial screen of the two coding exons (10 of 23 DNA fragments) for mutations in the proband of 21 unrelated families with autosomal dominant FECD have been performed using SSCP. Variant bands detected by SSCP were further analyzed by direct genomic sequencing. Results: One heterozygous variant band has been detected in one patient in exon 2. This exon corresponds to the triple helix domain of the protein and it is within this domain where mutations have been identified in COL8A2 in patients with FECD. Conclusion: To date, we have not found a pathogenic sequence alteration in the COL8A1 gene in patients with FECD. We are proceeding with sequence analysis of the DNA fragment corresponding to the variant band detected in exon 2 and an evaluation of the remaining DNA fragments from both exons in these patients.

Keywords: 335 candidate gene analysis • 370 cornea: basic science • 420 genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×